Curlew Bio
Developing small molecule as a novel anti-inflammatory modality. A modality with potential for broad application to autoimmune and inflammatory diseases.
Oral small molecule modulators to prevent immune cell migration and treat inflammation
Curlew Bio is the second company in the Brisbane Pod and the second
formed in collaboration with UniQuest.
Focus on inflammatory disease
Targeting a novel immunological pathway to reduce inflammation.
International project team
Experienced project team assembled with the goal of discovering and developing new medicines for inflammation.
